腹主动脉瘤腔内与开放修复的长期倾向评分匹配比较
该回顾性队列纳入819例肾下腹主动脉瘤择期修复患者,经倾向评分匹配后比较157对腔内修复与开放手术的长期结局。匹配队列5年总生存率分别为85.4%和90.1%,免于再干预率分别为81.1%和89.1%,差异均无统计学意义。作者认为在高风险较衰弱患者中两种修复方式长期结局相当。
要点
- 匹配后EVAR与开放手术5年生存率及免再干预率无显著差异
- 原始队列中开放手术5年生存率和免再干预率均优于EVAR
- 结果不支持在高风险较衰弱患者中常规优先选择EVAR
核心结论
- 经风险校正比较,较衰弱七旬左右患者中腔内修复与开放手术长期结局相当。
- 结果未显示EVAR在高风险患者中的长期优势,也未为选择标准提供支持证据。
研究设计与样本
- 纳入737例(386例EVAR、351例开放手术),随访超过1年或发生再干预/死亡事件。
- 倾向评分匹配协变量包括年龄、性别、高血压、冠心病、阻塞性肺病、糖尿病、卒中、恶性肿瘤、血液透析、射血分数、血肌酐和呼吸功能。
- 匹配后得到157对患者。
主要发现
- 原始队列5年总生存率EVAR为84.1%、开放手术为89.3%(P=0.019)。
- 原始队列5年免于再干预率EVAR为81.8%、开放手术为92.8%(P=0.007)。
- 匹配队列5年总生存率EVAR为85.4%、开放手术为90.1%(P=0.242)。
- 匹配队列5年免于再干预率EVAR为81.1%、开放手术为89.1%(P=0.178)。
临床怎么用
- 在高风险较衰弱患者中,EVAR与开放手术长期结局相当,选择应个体化。
- 不应仅依据长期再干预优势预期来决定EVAR适应证。
局限性
- 单中心回顾性设计,可能存在选择偏倚。
- 匹配后样本量有限,可能影响统计效能。
- 作者所在中心将EVAR适应证限制于高龄或体弱患者,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although recent guidelines recommend endovascular aneurysm repair (EVAR) for robust younger patients, we have been limiting our indication to older patients or those who are physically frail. This study compares long-term outcomes of our series of abdominal aortic aneurysms (AAAs) treated with endovascular repair (ER) and open surgery (OS), using propensity score matching. METHODS: Between June 2007 and October 2014, 819 patients with infrarenal AAA underwent elective repair at our institution. Among them, 737 patients (386 ERs and 351 OSs) with over 1-year follow-up or any events (reintervention or mortality) were enrolled. Covariates for matching included age, sex, hypertension, coronary arterial disease, obstructive pulmonary disease, diabetes, stroke, malignancy, hemodialysis, ejection fraction, serum creatinine, and respiratory function. RESULTS: After propensity score matching, 157 pairs were selected. In the original cohort, overall survival at 5 years was 84.1% in ER and 89.3% in OS; the difference was significant (P = 0.019). The freedom-from-reintervention rates at 5 years were also significantly different, 81.8% in ER and 92.8% in OS (P = 0.007). In the matched cohort, age and comorbidities were similar both in ER and OS. The overall survival at 5 years was 85.4% and 90.1% in ER and OS, respectively; the difference was not significant (P = 0.242). The freedom-from-reintervention rates at 5 years were 81.1% in ER and 89.1% in OS; these were also not significantly different (P = 0.178). CONCLUSIONS: Risk-adjusted comparisons revealed that long-term outcomes of ER and OS were comparable among our relatively frail patients in their age 70s. Our results failed to show the long-term advantage of EVAR in rather high-risk patients and provided no supportive evidence for our selection criteria.
引用
- Sugimoto M, Koyama A, Niimi K, et al. Long-term Comparison of Endovascular and Open Repair of Abdominal Aortic Aneurysms: Retrospective Analysis of Matched Cohorts with Propensity Score. Ann Vasc Surg. 2017. PMID: 28390921. doi:10.1016/j.avsg.2017.01.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。